As of August 25, 2026, the three major A-share indices moved in different directions. The Shanghai Composite Index closed up 0.19% at 3,889.44 points; the Shenzhen Component Index closed down 0.35% at 13,745.87 points; and the ChiNext Index closed down 1.00% at 3,397.52 points. Total trading value across the two markets was 1.83 trillion yuan.
Judging by industry momentum, small home appliances have performed remarkably well, surging 8.02% on the day. Cosmetics and real-estate services follow closely, rising 5.23% and 4.37%, respectively.
As of the close today, a total of 840 non-money-market ETFs across the entire market were up, with the proportion of those rising reaching 52%. The CSI Hong Kong-Hong Kong Stock Connect Medical Theme Index rose 3.91%; the CSI Hong Kong-Hong Kong Stock Connect Innovative Drug Index rose 3.06%; and the National Securities BioPharmaceuticals Index rose 2.97%.
Huabao Hong Kong Stock Connect Healthcare ETF (159137.SZ) latest share size has reached 158 million shares. The product closely tracks the CSI Hong Kong Stock Connect Healthcare Theme Index. The CSI Hong Kong Stock Connect Healthcare Theme Index selects 50 constituent stocks from within the Hong Kong Stock Connect eligible securities, whose businesses involve areas such as medical devices, medical commerce and services, pharmaceutical and biotechnology services, etc., to reflect the overall performance of healthcare-related listed companies within Hong Kong Stock Connect. The index constituent stocks include companies such as Tigermed Biotech, WuXi AppTec, JD Health, Genscript Biotech, WuXi Biologics (Wuhan) Co., Ltd., JingTai Holdings, Sinopharm Holdings, Alibaba Health, CSPC Pharmaceutical Group, BeiGene, and others.. The index weight holdings include WuXi Biologics, WuXi AppTec, JD Health, Genscript Biotech, WuXi (United) Medical, JingTai Holdings, Sinopharm Holdings, Alibaba Health, CSPC Pharmaceutical Group, BeiGene, and other companies.
Invesco Hong Kong Innovation Drug ETF (513780.SH) latest share size has reached 1.809 billion shares. The product closely tracks the CSI Hong Kong Stock Connect Innovation Drug Index. The CSI Hong Kong Stock Connect Innovation Drug Index selects 50 constituent stocks from within the Hong Kong Stock Connect universe, whose businesses involve innovation drug R&D and services such as drug research, development, and manufacturing for pharmaceutical companies, to reflect the overall performance of innovation drug listed companies within the Hong Kong Stock Connect universe. Index constituent stocks include companies such as WuXi Biologics, BeiGene, Innovent Biologics, WuXi AppTec, Conba, CSPC Pharmaceutical Group, Hansoh Pharmaceuticals, China Biopharmaceutical, Sinheng Pharmaceutical, and Kelun-Biotech, among others.
As of the market close today, a total of 685 non-money-market ETFs across the market fell, with the decline ratio reaching 42%. For industry theme indexes, the CSI Shanghai-Shenzhen-Hong Kong Gold Industry Stocks Index and the CSI Nonferrous Metals Mining Theme Index led the declines, falling 3.16% and 2.92%, respectively.
HuAn Gold Stocks ETF (159321.SZ) latest share size has reached 402 million shares. The product closely tracks the CSI Shanghai-Shenzhen-Hong Kong Gold Industry Stocks Index, focusing on the non-ferrous metals industry. Index constituent stocks include Zijin Mining, China Gold International, Chifeng Gold, Shandong Gold, Jinfeng International, Zhaojin Mining, Zijin Mining, Hunan Gold, China Gold International, Tongling Nonferrous, and other companies.
As of the market close today, the Nasdaq Technology market-cap weighted index was leading in terms of premium. The Nasdaq Technology ETF Invesco’s closing premium was 26.00%; the Nasdaq 100 index sentiment is surging.
